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AbstrACt
Introduction Systematic reviews collate trial data to 
provide evidence to support clinical decision-making. For 
effective synthesis, there must be consistency in outcome 
reporting. There is no agreed set of outcomes for reporting 
the effect of burn care interventions. Issues with outcome 
reporting have been identified, although not systematically 
investigated. This study gathers empirical evidence on any 
variation in outcome reporting and assesses the need for a 
core outcome set for burn care research.
Methods Electronic searches of four search engines were 
undertaken from January 2012 to December 2016 for 
randomised controlled trials (RCTs), using medical subject 
headings and free text terms including ‘burn’, ‘scald’ 
‘thermal injury’ and ‘RCT’. Two authors independently 
screened papers, extracted outcomes verbatim and 
recorded the timing of outcome measurement. Duplicate 
outcomes (exact wording ± different spelling), similar 
outcomes (albumin in blood, serum albumin) and identical 
outcomes measured at different times were removed. 
Variation in outcome reporting was determined by 
assessing the number of unique outcomes reported across 
all included trials. Outcomes were classified into domains. 
Bias was reduced using five researchers and a patient 
working independently and together.
results 147 trials were included, of which 127 (86.4%) 
were RCTs, 13 (8.8%) pilot studies and 7 (4.8%) RCT 
protocols. 1494 verbatim clinical outcomes were reported; 
955 were unique. 76.8% of outcomes were measured 
within 6 months of injury. Commonly reported outcomes 
were defined differently. Numbers of unique outcomes per 
trial varied from one to 37 (median 9; IQR 5,13). No single 
outcome was reported across all studies demonstrating 
inconsistency of reporting. Outcomes were classified into 
54 domains. Numbers of outcomes per domain ranged 
from 1 to 166 (median 11; IQR 3,24).
Conclusions This review has demonstrated heterogeneity 
in outcome reporting in burn care research which will 
hinder amalgamation of study data. We recommend the 
development of a Core Outcome Set.
PrOsPErO registration number CRD42017060908.
IntrOduCtIOn 
Each year an estimated 2–300 000 people die 
from burn injuries globally.1 Millions more 
suffer from burn-related disabilities and 
disfigurements.2 These injuries have func-
tional, psychological, social and economic 
effects on survivors and their families. There 
are multiple strategies for managing burn 
wounds and the associated impact on patient 
physiology, with new care pathways and tech-
nology being introduced on a regular basis.3–5 
The choice of treatment should be made using 
up-to-date, high quality scientific evidence.6 7 
Systematic reviews of randomised controlled 
trials (RCT) are regarded as the highest 
quality evidence.8–10 Despite increasing 
numbers of published RCTs in burn care, 
systematic reviews have not provided evidence 
to support many commonly used interven-
tions or management strategies.11–13 
A well-designed RCT requires that outcomes 
are prespecified. Evidence synthesis requires 
that these outcomes are consistent across 
RCTs in the same healthcare area.14 In the 
context of clinical trials, Williamson et al in 
the Core Outcome Measures in Effective-
ness Trials (COMET) handbook, define an 
outcome as ‘a measurement or observation 
used to capture and assess the effect of treat-
ment such as assessment of side effects (risk) 
or effectiveness (benefits)’.15 Chan adds a 
temporal element: ‘a variable measured at 
a specific time point to assess the efficacy or 
harm of an intervention’.16 If RCTs report 
outcomes that cannot be collated due to 
differences in choice, definition or timepoint 
strengths and limitations of this study
 ► This review is a comprehensive and systematic 
search for all clinical outcomes reported in ran-
domised controlled trials of burn care between and 
including 2012 and 2016.
 ► There is a detailed analysis of all reported outcomes 
and timing of outcome assessment.
 ► A multidisciplinary team including a patient were 
involved in the study.
 ► Quality assessment of studies was not undertaken 
as the purpose of the review was to extract clinical 
outcomes alone and not to assess the effect of an 
intervention.
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of assessment, evidence synthesis will not be effective or 
efficient. There is no agreed minimum set of outcomes 
important to patients and professionals for reporting in 
burn care trials and problems with outcome reporting in 
burn care research have previously been suggested.17–19
Prespecifying outcomes requires research to deter-
mine and agree the most important outcomes for a clin-
ical condition. If this is not undertaken, the outcomes 
reported may not reflect patients’ or other stakeholders’ 
needs, outcomes will vary between studies (outcome 
reporting heterogeneity), and it will be difficult to 
determine if authors have reported all the outcomes 
they measured (outcome reporting bias).20 21 Choosing 
the most important outcomes to measure in burn care 
is complex, as patients are a heterogeneous population, 
with variations in age, mechanism of injury, depth, site 
and size of burn.22 23 The time frame at which outcomes 
are measured may also determine the types of outcomes 
assessed. Outcomes reported in clinical trials during the 
acute treatment phase include healing time, skin-graft 
loss, infection rates and National Health Service costs.24–27 
Longer-term reported outcomes relate to functional, 
cosmetic and psychological issues.28
To date, there has been no formal investigation into 
outcome reporting in trials of burn care. The purpose 
of this study is to examine clinical outcome reporting in 
burn care research, to consider the types, definitions and 
timing of outcomes measured and to consider the need 
for a Core Outcome Set (COS) in this field.
MEthOds
This review is focused on clinical, observer-reported 
outcomes in RCTs assessing the impact of interventions 
in burn care. It adhered to a prespecified protocol and 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement.29
study eligibility
Studies were included if they met the following:
Types of studies: We included full text RCTs along with 
RCT protocols and pilot studies. The study design was 
limited to RCTs, as any final COS will be used for RCT 
reporting.29 We excluded protocols and pilot studies if 
the full RCT had been published within the selected time 
period. We also excluded conference proceedings and 
abstracts, non-English language publications and studies 
not involving human subjects.
Types of participants: We included studies recording 
outcomes from patients of any age with a cutaneous burn 
of any type or size, determined by either clinician eval-
uation or objective assessment, or both, which required 
treatment in any healthcare facility. Studies where the 
population consisted of patients with combined thermal 
and mechanical injuries were only included if it was 
possible to separate out the burn care outcomes. Trials 
studying patients with pure carbon monoxide poisoning, 
chemical ocular or caustic oesophageal burns were 
excluded, as the former does not involve a burn and the 
latter have different aetiology and management to cuta-
neous burns.
Type of interventions: Any surgical or non-surgical burn 
care intervention with any appropriate comparator.
Types of outcomes: Defined as the exact terms used in 
a published trial abstract, methods or results including 
tables and figures for any observer-reported clinical 
endpoint. These included physiological, metabolic or 
adverse or mortality events measured by researchers and 
relevant to patients’ recovery and long-term well-being 
after burn care.30 Trials assessing quality of life were only 
included if the data were observer-reported.
Identification of studies
Electronic searches of Ovid MEDLINE, Ovid EMBASE, 
Web of Science and The Cochrane Library were 
searched from 1 January 2012 to 31 December 2016 
for RCTs related to burn care using medical subject 
heading and free text terms including ‘burn’, ‘scald’ 
‘thermal injury’ and ‘RCT’. This period was chosen 
so that the outcomes extracted, reflected use in trials 
relating to modern burn care. Limiting the review 
to 5 years allowed us to balance workload against the 
likelihood of selecting enough trials fulfilling inclu-
sion criteria to demonstrate whether heterogeneity of 
outcome reporting was present in burn care research. 
The thesaurus vocabulary of each database was used to 
adapt the search terms. The search strategy for Ovid 
MEDLINE is included in a previous publication and 
in  online supplementary appendix A.29
study selection process
Prior to both abstract and full-text screening, all review 
authors underwent training to ensure a comparable 
understanding of the purpose of the review and the 
eligibility criteria. The reference management soft-
ware EndNote V.6 (Clarivate Analytics, Boston; avail-
able at http:// endnote. com/) was used to compile all 
titles derived from the initial searches, with duplicates 
removed for the review authors to screen titles and 
abstracts against the eligibility criteria. Screening of 
titles and abstracts was completed independently, then 
in duplicate by two authors (AY, AD) with experience in 
systematic review methodology. All screening disagree-
ments were discussed, with any outstanding disagree-
ments resolved by an independent reviewer (JB). Any 
studies appearing to meet the inclusion criteria based 
on the abstract were retrieved as full-text articles. Two 
reviewers then read the full-text articles in their entirety 
to assess for eligibility, with decisions on inclusion and 
exclusion recorded (figure 1 for flow diagram). Reasons 
for exclusion were ordered hierarchically (box 1) and 
applied to each full text. The highest reason for exclu-
sion met by a paper was recorded as its reason for exclu-
sion. Any disagreements were discussed with another 
author (JB).
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Quality assessment
The aim of this study was to comprehensively document 
any variation in clinical outcomes selected, defined, 
measured and reported in burn care RCTs and not to 
synthesise data about the effect of interventions. Inclu-
sion of all trials was necessary to demonstrate if a variation 
in outcome reporting was present across trials, regard-
less of quality of methodology of the trial. We therefore 
decided not to undertake a quality assessment of studies 
because it was not relevant to the data being recorded 
in this review; simply the nature and description of the 
unique outcomes reported in each study.
data extraction
Data were extracted into a standardised data extraction 
sheet (Microsoft Excel). This included study author, 
country or countries recruiting (categorised into the 
United Nations six regions31), publication year, number 
of sites and number of participants recruited per trial, 
design (full RCT, pilot, protocol) and intervention tested. 
For protocols, the planned participant inclusion criteria 
and sample size were extracted.
No distinction was made between primary or secondary 
outcomes, although this was noted and is part of a sepa-
rate project. All outcomes were extracted verbatim, with 
20% of the extracted data verified by a second reviewer. 
True duplicates, spelled and worded the same, were 
deleted. As a second process, two reviewers (a clinician 
and researcher) discussed all verbatim outcomes to assess 
duplicates in meaning but spelled or worded in a slightly 
different manner; such as length of time in hospital and 
number of days in hospital, platelet level and levels, and 
serum interleukin (IL) 10 and IL-10 in blood. These 
were named as one outcome with wording chosen by 
the reviewers and the others deleted as duplicates. The 
remaining outcomes were therefore all different in 
meaning. Any discrepancies were discussed with a senior 
researcher (JB). The number of outcomes per trial and 
the variation of outcomes between trials was recorded.
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. PRO, patient reported outcome; 
RCT, randomised controlled trial. 
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The time after injury that outcomes were measured 
were noted separately in order to (a) assess the hetero-
geneity in outcome measurement timing and (b) to 
understand at what stage after injury the effects of the 
intervention were being assessed. If a single outcome was 
assessed at different timepoints, all assessment timings 
were recorded. Data extraction for the timing of outcome 
reporting from 10% of trials was undertaken inde-
pendently by another researcher. Timings of outcome 
assessment were categorised into time periods; <1 month, 
>1 month and <3 months, >3 months and <6 months 
after injury, >6 months and <1 year and >1 year and <3 
years, and >3 years. We reported two other outcome time 
periods; those assessed during acute hospitalisation and 
during burn wound healing, as these were commonly 
reported in the literature with no proscribed timepoint. 
However, it was clear from the reported length of stay and 
healing data, that all these outcomes were assessed within 
6 months of injury. The frequency of outcomes reported 
within each time period was recorded.
The data were tabulated so that each study was listed 
with study and population details along with outcomes 
measured. Outcomes were extracted from this spread-
sheet into another, with duplicates removed as described 
above. Outcomes measuring the same healthcare issue 
but at different timepoints were noted as one outcome 
for the final set. These final unique outcomes were then 
grouped into domains.
Classification of outcomes into domains
Outcome domains are groups of similar outcomes. This 
organisation is necessary, as maintaining a large set of 
outcomes when a significant number are similar, would 
make any future classification of the outcomes in terms of 
importance, extremely challenging.
Outcomes were classified into domains in a three-
stage iterative approach. In stage 1, four researchers 
(a clinically trained burn care researcher, a burn 
research associate and two senior research nurses expe-
rienced in burn care) independently reviewed the list 
of outcomes and attributed a potential domain to each 
one using their own terms. In stage 2, the researchers 
met to review the domains and agreed (1) appropriate 
groupings of outcomes into domains and (2) an appro-
priate name for each domain. Rules for attribution of 
outcomes to domains were recorded in a coding log to 
ensure consistency. In stage 3, a patient representative 
reviewed the outcomes and their attributed domains to 
check for clarity of domain name, and that the outcomes 
under each domain were appropriately attributed. A 
final meeting with an experienced outcome researcher 
was held to finalise outcomes and domains. The use of 
a published classification system was not undertaken as 
none appeared to allow the flexibility or fit to the types of 
outcomes reported in burn care trials.32 33
The results described below indicate the characteristics 
of the reported studies and provide detail on heteroge-
neity of outcome reporting between studies, outcome 
definitions, timepoints and outcome domains.
Patient involvement
The need for a burn care COS project was conceived 
following discussions regarding clinical healthcare Key 
Performance Indicators with professionals and patients. 
The patients were vocal about outcomes important to them 
which they felt were overlooked by professionals, such as 
pain. The systematic review was discussed at regular project 
steering group meetings attended by three patients with 
burns and one parent of a child with burns. A patient with 
burns is a coauthor and was involved with writing and editing 
of this article as well as with the naming of the outcome 
domains. Dissemination will be to the lay representatives of 
the steering group and will inform the Core Outcome Set 
study in which patients are actively involved.
rEsults
Included studies and study protocols
The initial search strategy identified 3110 studies. Following 
de-duplication, a total of 2070 studies remained. Indepen-
dent scrutiny of the titles and abstracts identified 306 poten-
tially relevant articles for full text review. Of these, 158 studies 
did not meet our inclusion criteria and were excluded 
(PRISMA flow diagram; figure 1). Therefore, a total of 147 
studies formed the basis of this study.24 34–178
studies
Of the 147 studies (table 1), 86.4% (127) were reports 
of full RCTs, 8.8% (13) were pilot studies and 4.8% (7) 
were study protocols. The number of studies published 
increased between 2012 and 2016, with 26 RCTs published 
in 2012 and 40 in 2016 (table 2).
box 1 hierarchy of exclusion
1. Duplicate.
2. Not published between 1 January 2012 and 31 December 2016.
3. Not written in English.
4. Not relating to burns or burn care alone.
5. Population is non-human subjects (eg, animal studies, modelling).
6. Abstract with no full text given.
7. Study is not a randomised controlled trial testing an intervention 
on burn care.
8. Laboratory based, not carried out in clinical setting, for example, 
exudate or blood samples from humans tested within laboratory.
9. Systematic review paper, commentary paper.
10. Reports only patient-reported outcomes.
11. Volunteer study.
12. Oesophageal burns.
13. Ocular burns.
14. Anaesthetic/sedation technique.
15. Diagnostic test trial.
16. Unavailable anywhere.
17. Follow-up studies.
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Table 1 Included randomised controlled trials
Trial title First author
Year of 
publication
1. Comparison of silver nylon wound dressing and silver sulfadiazine in partial burn wound 
therapy.34
Abedini 2012
2. Healing of burn wounds by topical treatment: A randomized controlled comparison 
between silver sulfadiazine and nano-crystalline silver.35
Adhya
2015
3. An analysis of deep vein thrombosis in burn patients (Part 1): Comparison of D-dimer and 
Doppler ultrasound as screening tools.36
Ahuja
2016
4. An analysis of deep vein thrombosis in burn patients (part II): A randomized and controlled 
study of thrombo-prophylaxis with low molecular weight heparin.37
Ahuja
2016
5. A four arm, double blind, randomized and placebo-controlled study of pregabalin in the 
management of post-burn pruritus.38
Ahuja
2012
6. Propranolol attenuates haemorrhage and accelerates wound healing in severely burned 
adults.39
Ali
2015
7. Aerobic exercise training in modulation of aerobic physical fitness and balance of burned 
patients.40
Ali
2015
8. Silk sericin ameliorates wound healing and its clinical efficacy in burn wounds.41 Aramwit 2013
9. A Randomized Controlled Trial Comparing Endoscopic-Assisted Versus Open Neck Tissue 
Expander Placement in Reconstruction of Post-Burn Facial Scar Deformities.42
As’adi
2016
10. A prospective, randomised study of a novel transforming methacrylate dressing 
compared with a silver-containing sodium carboxymethylcellulose dressing on partial-
thickness skin graft donor sites in burn patients.43
Assadian
2015
11. Multimodal quantitative analysis of early pulsed-dye laser treatment of scars at a 
pediatric burn hospital.44
Bailey
2012
12. Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a 
randomized, controlled, double-blind clinical trial.45
Bechir
2013
13. A prospective randomized trial comparing silver sulfadiazine cream with a water-soluble 
poly-antimicrobial gel in partial-thickness burn wounds.46
Black
2015
14. Clinical effectiveness of dermal substitution in burns by topical negative pressure: a 
multicenter randomized controlled trial.47
Bloeman
2012
15. Effect of subcutaneous epinephrine/saline/local anesthetic versus saline-only injection on 
split-thickness skin graft donor site perfusion, healing, and pain.48
Blome Eberwein
2013
16. A randomized controlled study of silver-based burns dressing in a pediatric emergency 
department.49
Brown
2016
17. Cost-Effectiveness of a Nonpharmacological Intervention in Pediatric Burn Care.50 Brown 2015
18. Play and heal: randomized controlled trial of DittoTM intervention efficacy on improving 
re-epithelialization in pediatric burns.51
Brown
2013
19. The implementation and evaluation of therapeutic touch in burn patients: an instructive 
experience of conducting a scientific study within a non-academic nursing setting.
Busch
2012
20. Prophylactic sequential bronchoscopy after inhalation injury: results from a 3 year 
prospective randomized trial.52
Carr
2013
21. Burns injury in children: is antibiotic prophylaxis recommended?53 Chahed 2014
22. A randomized controlled trial to compare the effects of liquid versus powdered 
recombinant human growth hormone in treating patients with severe burns.54
Chen
2016
23. The Effect of Continuous Sedation Therapy on Immunomodulation, Plasma Levels of 
Antioxidants, and Indicators of Tissue Repair in Post-Burn Sepsis Patients.55
Chen
2015
24. Application of acellular dermal xenografts in full-thickness skin burns.56 Chen 2013
25. Effectiveness of medical hypnosis for pain reduction and faster wound healing in 
pediatric acute burn injury: study protocol for a randomized controlled trial.57
Chester
2016
26. Safety of recombinant human granulocyte-macrophage colony-stimulating factor in 
healing paediatric severe burns.58
Chi
2015
27. Comparison of three cooling methods for burn patients: A randomized clinical trial.59 Cho 2016
Continued
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Trial title First author
Year of 
publication
28. The effect of burn rehabilitation massage therapy on hypertrophic scar after burn: a 
randomized controlled trial.60
Cho
2014
29. Effect of extracorporeal shock wave therapy on scar pain in burn patients: A prospective, 
randomized, single-blind, placebo-controlled study.61
Cho
2016
30. Characterization of early thermal burns and the effects of hyperbaric oxygen treatment: a 
pilot study.62
Chong
2013
31. Effects of different duration exercise programs in children with severe burns.63 Clayton 2016
32. The effect of healing touch on sleep patterns of pediatric burn patients.64 Cone 2014
33. Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe 
burn.65
Csontos
2012
34. The effects of intravenous glutamine supplementation in severely burned, multiple 
traumatized patients.66
Cucerean-Badica
2013
35. A comparison between occlusive and exposure dressing in the management of burn 
wound.
Dallal
2016
36. Evaluation of the ‘Early’ Use of Albumin in Children with Extensive Burns: A Randomized 
Controlled Trial.
Dittrich
2016
37. Interim pressure garment therapy (4–6 mmHg) and its effect on donor site healing in burn 
patients: study protocol for a randomised controlled trial.67
Donovan
2016
38. Effect of whole body vibration on leg muscle strength after healed burns: a randomized 
controlled trial.68
Ebid
2012
39. Effect of isokinetic training on muscle strength, size and gait after healed pediatric burn: 
a randomized controlled study.69
Ebid
2014
40. Effect of 12 week isokinetic training on muscle strength in adult with healed thermal 
burn.70
Ebid
2012
41. Effects of whole-body vibration exercise on bone mineral content and density in 
thermally injured children.71
Edionwe
2016
42. Efficacy of platelet rich plasma application in comparison to conventional dressing 
therapy in partial thickness burn wound.72
Ehmer al Ibran
2014
43. Effect of probiotic administration in the therapy of pediatric thermal burn.73 El-ghazely 2016
44. Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a 
study of different doses.74
Elsharnouby
2014
45. The effect of levamisole on mortality rate among patients with severe burn injuries.75 Fatemi 2013
46. Impact of stress-induced diabetes on outcomes in severely burned children.76 Finnerty 2014
47. Outcome of Burns Treated With Autologous Cultured Proliferating Epidermal Cells: A 
Prospective Randomized Multi-center Intra-patient Comparative Trial.77
Gardien
2016
48. Randomized controlled trial of three burns dressings for partial thickness burns in 
children.78
Gee Kee
2015
49. Topical petrolatum gel alone versus topical silver sulfadiazine with standard gauze 
dressings for the treatment of superficial partial thickness burns in adults: a randomized 
controlled trial.79
Genuino
2014
50. HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in 
burn patients with inhalation trauma: study protocol for a multi-center randomized controlled 
trial.80
Glas
2014
51. A multi-center study on the regenerative effects of erythropoietin in burn and scalding 
injuries: study protocol for a randomized controlled trial.82
Gunter
2013
52. Early rehabilitative exercise training in the recovery from pediatric burn.83 Hardee 2014
53. Quality of pediatric second-degree burn wound scars following the application of basic 
fibroblast growth factor: results of a randomized, controlled pilot study.84
Hayashida
2012
54. Long-term propranolol use in severely burned pediatric patients: a randomized controlled 
study.85
Herndon 2012
Table 1 Continued 
Continued
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Trial title First author
Year of 
publication
55. Reversal of growth arrest with the combined administration of oxandrolone and 
propranolol in severely burned children.86
Herndon
2016
56. Cost-Effectiveness of Laser Doppler Imaging in Burn Care in The Netherlands: A 
Randomized Controlled Trial.87
Hop
2016
57. Effect of music intervention on burn patients’ pain and anxiety during dressing 
changes.88
Hsu
2016
58. Low dose of glucocorticoid decreases the incidence of complications in severely burned 
patients by attenuating systemic inflammation.89
Huang
2015
59. An assessment of early Child Life Therapy pain and anxiety management: A prospective 
randomised controlled trial.90
Hyland
2015
60. Prospective, randomised controlled trial comparing VersajetTM hydrosurgery and 
conventional debridement of partial thickness paediatric burns.91
Hyland
2015
61. Construction of skin graft seams in burn patients: A prospective randomized double-
blinded study.92
Isaac
2016
62. Multi-axis shoulder abduction splint in acute burn rehabilitation: a randomized controlled 
pilot trial.93
Jang
2015
63. Glucose control in severely burned patients using metformin: An interim safety and 
efficacy analysis of a phase II randomized controlled trial.94
Jeschke
2016
64. The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical 
outcomes.95
Jeschke
2012
65. The Effect of Distraction Technique on the Pain of Dressing Change among 3–6 Year-old 
Children.96
Kaheni
2016
66. Prospective randomize-controlled comparison between silicone plus herbal extract gel 
versus Aloe Vera gel for burn scar prophylaxis.97
Keorochana
2015
67. Effects of Enteral Glutamine Supplementation on Reduction of Infection in Adult Patients 
with Severe Burns.98
Kibor
2014
68. Effects of sustained release growth hormone treatment during the rehabilitation of adult 
severe burn survivors.99
Kim
2016
69. Virtual reality for acute pain reduction in adolescents undergoing burn wound care: a 
prospective randomized controlled trial.100
Kipping
2012
70. The effects of splinting on shoulder function in adult burns.101 Kolmus 2012
71. Prospective study on burns treated with Integra, a cellulose sponge and split thickness 
skin graft: comparative clinical and histological study--randomized controlled trial.102
Lagus
2013
72. Evaluation of an oxygen-diffusion dressing for accelerated healing of donor-site 
wounds.103
Lairet
2014
73. Anti-inflammatory effect of taurine in burned patients.104 Lak 2015
74. A randomized controlled pilot study comparing aqueous cream with a beeswax and 
herbal oil cream in the provision of relief from postburn pruritus.105
Lewis
2012
75. Human acellular dermal matrix allograft: A randomized, controlled human trial for the 
long-term evaluation of patients with extensive burns.106
Li
2015
76. Selective digestive decontamination attenuates organ dysfunction in critically ill burn 
patients.107
Lopez-Rodriguez
2015
77. Results of a prospective randomized controlled trial of early ambulation for patients with 
lower extremity autografts.108
Lorello
2014
78. Moist occlusive dressing (Aquacel(Â) Ag) versus moist open dressing (MEBO(Â)) in 
the management of partial-thickness facial burns: a comparative study in Ain Shams 
University.109
Mabrouk
2012
79. Enhancement of burn wounds healing by platelet dressing.110 Maghsoudi 2013
80. Effect of immune-enhancing diets on the outcomes of patients after major burns.111 Mahmoud 2014
Table 1 Continued 
Continued
 o
n
 5 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025135 on 15 February 2019. Downloaded from 
8 Young AE, et al. BMJ Open 2019;9:e025135. doi:10.1136/bmjopen-2018-025135
Open access 
Trial title First author
Year of 
publication
81. Silver-coated nylon dressing plus active DC microcurrent for healing of autogenous skin 
donor sites.112
Malin
2013
82. The application of platelet-rich plasma in the treatment of deep dermal burns: A 
randomized, double-blind, intra-patient-controlled study.113
Marck
2016
83. Clinical safety and efficacy of probiotic administration following burn injury.114 Mayes 2015
84. Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a 
randomised controlled trial.115
McBride
2015
85. Evaluation of who oral rehydration solution (ORS) and salt tablets in resuscitating adult 
patients with burns covering more than 15% of total body surface area (TBSA).116
Moghazy
2016
86. Efficacy and adverse events of early high-frequency oscillatory ventilation in adult burn 
patients with acute respiratory distress syndrome.117
Mohamed
2016
87. Effect of amniotic membrane on graft take in extremity burns.118 Mohammadi 2013
88. Comparison of the application of allogeneic fibroblast and autologous mesh grafting with 
conventional method in the treatment of third-degree burns.119
Moravvej
2016
89. Effect of low-intensity laser on the neuropathic common peroneal nerve post burn.120 Mowafy 2016
90. Clinical Efficacy Test of Polyester Containing Herbal Extract Dressings in Burn Wound 
Healing.121
Muangman
2016
91. Effect of oral olive oil on healing of 10%–20% total body surface area burn wounds in 
hospitalized patients.123
Najmi
2015
92. Double-blind, randomized, pilot study assessing the resolution of postburn pruritus.124 Nedelec 2012
93. Comparing outcomes of sheet grafting with 1:1 mesh grafting in patients with thermal 
burns: a randomized trial.125
Nikkah
2014
94. Comparison of hydrogel produced by radiation as applied at the research center (Yazd 
branch) with maxgel and routine dressing for second-degree burn repair in Yazd burn 
hospital.126
Noorbala
2016
95. Effectiveness of cerium nitrate-silver sulfadiazine in the treatment of facial burns: a multi-
center, randomized, controlled trial.127
Oen
2012
96. Influences of purposeful activity versus rote exercise on improving pain and hand 
function in pediatric burn.128
Omar
2012
97. Botulinum toxin and burn induces contracture.130 Omranifard 2016
98. Results of a pilot multi-center genotype-based randomized placebo-controlled trial of 
propranolol to reduce pain after major thermal burn injury.129
Orrey
2015
99. A proper enteral nutrition support improves sequential organ failure score and decreases 
length of stay in hospital in burned patients.131
Ostradrahimi
2016
100. Topical silver sulfadiazine vs collagenase ointment for the treatment of partial thickness 
burns in children: a prospective randomized trial.132
Ostlie
2012
101. Prospective randomized phase II Trial of accelerated re-epithelialization of superficial 
second-degree burn wounds using extracorporeal shock wave therapy.133
Ottomann
2012
102. A randomized and controlled multi-center prospective study of the Chinese medicinal 
compound Fufang Xuelian Burn Ointment for the treatment of superficial and deep second-
degree burn wounds.134
Ouyang
2014
103. Prospective comparison of packed red blood cell-to-fresh frozen plasma transfusion 
ratio of 4: 1 vs 1: 1 during acute massive burn excision.135
Palmieri
2012
104. A herbal cream consisting of Aloe Vera, Lavandulastoechas, and Pelargonium roseum 
as an alternative for silver sulfadiazine in burn management.136
Panahi
2012
105. Interactive gaming consoles reduced pain during acute minor burn rehabilitation: A 
randomized, pilot trial.137
Parker
2016
106. A Pilot Prospective Randomized Control Trial Comparing Exercises Using Videogame 
Therapy to Standard Physical Therapy: 6 Months Follow-Up.138
Parry 2015
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Trial title First author
Year of 
publication
107. An open, prospective, randomized pilot investigation evaluating pain with the use of a 
soft silicone wound contact layer vs bridal veil and staples on split thickness skin grafts as a 
primary dressing.139
Patton
2013
108. Effects of community-based exercise in children with severe burns: A randomized 
trial.140
Pena
2015
109. Effects of propranolol and exercise training in children with severe burns.141 Porro 2013
110. Five-year outcomes after oxandrolone administration in severely burned children: a 
randomized clinical trial of safety and efficacy.142
Porro
2012
111. Clinical effectiveness, quality of life and cost-effectiveness of Flaminal versus Flamazine 
in the treatment of partial thickness burns: study protocol for a randomized controlled trial.144
Rashaan
2016
112. Five-Year Outcomes after Long-Term Oxandrolone Administration in Severely Burned 
Children: A Randomized Clinical Trial.145
Reeves
2016
113. A novel rapid and selective enzymatic debridement agent for burn wound management: 
a multi-center RCT.146
Rosenburg
2013
114. Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D 
status, muscle strength and bone health: a 1 year pilot randomized controlled trial in adults 
with severe burns.147
Rousseau
2015
115. Evaluation of Amniotic Membrane Effectiveness in Skin Graft Donor Site Dressing in 
Burn Patients.148
Salehi
2015
116. A feasibility study assessing cortical plasticity in chronic neuropathic pain following 
burn injury.143
Santos Portilla
2013
117. Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood 
product requirements.149
Schaden
2012
118. A prospective clinical trial comparing Biobrane, Dressilk, and PolyMem dressings on 
partial-thickness skin graft donor sites.150
Schulz
2016
119. Effectiveness of Aloe Vera gel compared with 1% silver sulphadiazine cream as burn 
wound dressing in second degree burns.151
Shahzad
2013
120. The comparison between modified kligman formulation versus kligman formulation and 
intense pulsed light in the treatment of the post-burn hyperpigmentation.152
Siadat
2016
121. A comparative study of spray keratinocytes and autologous meshed split-thickness skin 
graft in the treatment of acute burn injuries.154
Sood
2015
122. Long-Term Administration of Oxandrolone Improves Lung Function in Pediatric Burned 
Patients.155
Sousse
2016
123. An open, parallel, randomized, comparative, multicenter investigation evaluating the 
efficacy and tolerability of Mepilex Ag versus silver sulfadiazine in the treatment of deep 
partial-thickness burn injuries.156
Tang
2015
124. Non-ablative fractional laser provides long-term improvement of mature burn scars - A 
randomized controlled trial with histological assessment.157
Taudorf
2015
125. Fluid therapy lidco controlled trial - Optimization of volume resuscitation of extensively 
burned patients through noninvasive continuous real-time hemodynamic monitoring 
LiDCO.158
Tokarik
2013
126. Burn donor site dressing using melolin and flexigrid versus conventional dressing.159 Vejdan 2015
127. Laser Doppler imaging as a tool in the burn wound treatment protocol.160 Venclauskiene 2014
128. Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a 
randomized clinical trial.161
Venet
2015
129. A Comparative Study of Paediatric Thermal Burns Treated with Topical Heparin and 
Without Heparin.162
Venkatachalapathy
2014
130. Aquacel() Ag dressing versus ActicoatTM dressing in partial thickness burns: a 
prospective, randomized, controlled study in 100 patients. Part 1: burn wound healing.24
Verbelen
2014
131. Skin stretching for primary closure of acute burn wounds.163 Verhaegen 2014
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A total of 9022 participants were recruited across the 
140 studies (study protocols not included n=7). The 
number of patients recruited per trial ranged from 3 to 
612 (median 50; IQR 30–88) for full RCTs and from 10 
to 52 (median 21; IQR 16–28) for pilot studies. 50.4% of 
full RCTs recruited fewer than 50 participants (table 2). 
The majority (89.7%) of studies recruited (or planned to 
recruit) participants on one site alone. Of the 10.2% (15) 
of studies that were multicentre, nine (60%) undertook 
research at only two or three sites. Thirty-two countries 
from the six global regions recruited patients into the 
147 RCTs (table 2). The country that undertook the most 
studies was the USA with 22.4% (33), followed by Iran 
with 12.9% (19) and China with 10.9% (16) of published 
studies. Of the 32 countries, 59.3% (19) published only 
one trial in this time period. The most common trial 
interventions related to dressings and wound care 29.2% 
(43), followed by surgical technique 11.6% (17) and 
management of pain and itch 10.9% (16) (table 2).
Outcomes
A total of 1494 clinical outcomes were reported of which, 
after de-duplication, 955 different, unique outcomes 
remained. Of the 1494 outcomes reported, 27.7% 
(421) were common across two studies or more. Of these 
outcomes, 50.3% (78) appear in only two trials and 84.5% 
appear in five trials or fewer. The number of outcomes 
reported per trial varied from one to 37 (median 9; IQR 
5,13) (table 3). No single outcome was reported across all 
147 studies.
Outcome definition variation: Outcomes assessing the 
same healthcare issue were commonly defined differently. 
An example is burn wound healing which was defined in 
166 different ways. Examples include: healing percentage 
Trial title First author
Year of 
publication
132. Xbox KinectTM based rehabilitation as a feasible adjunct for minor upper limb burns 
rehabilitation: A pilot RCT.164
Voon
2016
133. Local application of low-dose insulin in improving wound healing after deep burn 
surgery.165
Wang
2016
134. Gabapentin is ineffective as an analgesic adjunct in the immediate postburn period.166 Wibbenmeyer 2014
135. A prospective randomised clinical pilot study to compare the effectiveness of Biobrane 
(R) synthetic wound dressing, with or without autologous cell suspension, to the local 
standard treatment regimen in paediatric scald injuries.167
Wood
2012
136. Effective symptomatic treatment for severe and intractable pruritus associated with 
severe burn-induced hypertrophic scars: A prospective, multicenter, controlled trial.168
Wu
2016
137. Propranolol reduces cardiac index but does not adversely affect peripheral perfusion in 
severely burned children.169
Wurzer
2016
138. A new method of microskin autografting with a Vaseline-based moisture dressing on 
granulation tissue.170
Xiao
2014
139. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel 
promotes healing of deep partial thickness burn wounds.171
Yan
2012
140. A comparative study of the dressings silver sulfadiazine and Aquacel Ag in the 
management of superficial partial-thickness burns.172
Yarboro
2013
141. A clinical trial designed to evaluate the safety and effectiveness of a thermosensitive 
hydrogel-type cultured epidermal allograft for deep second-degree burns.173
Yim
2014
142. Study of the use of recombinant human granulocyte-macrophage colony-stimulating 
factor hydrogel externally to treat residual wounds of extensive deep partial-thickness 
burn.174
Yuan
2015
143. Effect of Olea ointment and Acetate Mafenide on burn wounds - A randomized clinical 
trial.175
Zahmatkesh
2015
144. Effects of puerarin on the inflammatory role of burn-related procedural pain mediated 
by P2×7 receptors.176
Zhang
2013
145. Effects of early enteral nutrition on the gastrointestinal motility and intestinal mucosal 
barrier of patients with burn-induced invasive fungal infection.81
Zhang
2016
146. Maximizing the safety of glycerol preserved human amniotic membrane as a biological 
dressing.177
Zidan
2015
147. Therapeutic Value of Blood Purification and Prognostic Utilities of Early Serum 
Procalcitonin, C Reactive Protein, and Brain Natriuretic Peptide Levels in Severely Burned 
Patients with Sepsis.178
Zu
2015
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at specified timepoints, incidence of complete wound 
healing, incidence of 30% wound healing and length of 
time until 50% epithelialisation of burn wound. Similar 
variation in definition of burn wound infection existed 
with 79 unique outcome definitions including: bacterial 
colonisation of burn wound, days of antibiotics, incidence 
of local infection, incidence of positive wound cultures, 
periwound redness, rate of bacterial clearance from 
wound and number of inflammatory cells in the wound.
Outcome timing variation: There were 2743 outcomes 
measured if the same outcome measured at different 
timepoints across all the 147 RCTs are included; for 
example, size of burn wound measured at 1 week and 
again at 2 weeks, were recorded as different outcomes for 
this exercise. Of these, 76.9% (2109) were assessed at less 
than 6 months after injury, 16.6% (456) were measured 
after 6 months and before 3 years after injury, and only 
5.1% (140) were measured at more than 3 years after 
injury (figure 2). The timing of outcome measurement 
was not reported for 38 outcomes.
Outcome domains: The 955 different clinical outcomes 
were organised into 54 domains (groups of similar 
outcomes). Table 4 categorises the domains into over-
arching categories and gives examples and total numbers 
of outcomes within each domain.
Table 2 Randomised controlled tiral (RCT) detail
Studies
Number of RCTs 127/147 (86.4)
Number of pilot studies 13/147 (8.8)
Number of RCT protocols 7/147 (4.8)
World region for recruitment
  Asia 54/147 (36.7)
  North America 36/147 (24.5)
  Europe 26/147 (17.7)
  Africa 15/147 (8.5)
  Latin America 1/147 (0.7)
  Australasia 15/147 (8.5)
Year published
  2012 26/147 (17.8)
  2013 24/147 (16.3)
  2014 24/147 (16.3)
  2015 33/147 (22.4)
  2016 40/147 (27.2)
Number of sites
  1 132/147 (89.8)
  2–3 9/147 (6.1)
  4–5 2/147 (1.4)
  >5 4/147 (2.7)
Number of participants in full RCTs
  <10 4/127 (3.1)
  11–50 62/127 (48.8)
  51–100 39/127 (30.7)
  101–150 11/127 (8.7)
  >150 11/127 (8.7)
Participants recruited
  <18 years 24/147 (16.3)
  >18 years 59/147 (40.1)
  Mixed age range 25/147 (17.0)
  Not stated 34/147 (23.1)
  N/A (protocol)‡  5/147 (3.4)
Type of intervention
  Dressings and wound care 38/147 (25.9)
  Surgical technique 19/147 (12.9)
  Treatment of pain or itch* 16/147 (10.9)
  Impact of exercise and rehabilitation 13/147 (8.8)
  Intensive care management 10/147 (6.8)
  Treatment of hypermetabolism 8/147 (5.4)
  Nutrition 8/147 (5.4)
  Scar management 7/147 (4.8)
  Treatment of inhalational injury 3/147 (2.0)
  Use of topical rHGM 3/147 (2.0)
  Use of rHGH 3/147 (2.0)
Continued
Studies
  Sugar management 2/148 (2.0)
  Treatment of infection 2/147 (1.4)
  Treatment of DVT 2/147 (1.4)
  Blood management 2/147 (1.4)
  Extracorporeal shock wave therapy 2/147 (1.4)
  Platelet-rich plasma use 2/147 (1.4)
  Others† 7/147 (5.4)
*Inc. distraction for dressing changes.
†Inc. levamisole, hyperbaric oxygen, fibroblast growth factor, oral 
calcium use, ketoconazole, low intensity laser.
‡No participants reported as study is a protocol.
DVT, deep vein thrombosis; N/A, not applicable; rHGH, 
recombinant human growth hormone; rHGM, recombinant Human 
Granulocyte-Macrophage colony-stimulating factor.
Table 2 Continued 
Table 3 Reported outcomes
Number of outcomes per 
study
1 4/147 (27.2%)
2–5 34/147 (23.1%)
6–10 53/147 (36.1%)
11–20 41/147 (27.9%)
>20 15/147 (10.2%)
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dIsCussIOn
This systematic review aimed to examine outcome 
reporting in RCTs in burn care. Of the 147 included 
studies, 1494 outcomes were identified with 955 of these 
unique. There was overlap in terminology, inconsistent 
definitions and variation in time after injury at which the 
outcomes were measured. Only 30% of the outcomes 
reported were included in more than one study. There 
was no single outcome reported across all 147 trials. 
Commonly-reported outcomes were defined differ-
ently between trials, such as burn wound healing which 
was defined in 166 different ways. Such heterogeneity 
of outcome reporting across trials will limit evidence 
synthesis and result in research wastage.
The findings in this review have been seen elsewhere 
in the burns-specific and other clinical literature. A 
Cochrane review of 30 RCTs concluded that it was 
impossible to draw conclusions about burn dressing 
effectiveness, as the trials evaluated a variety of clin-
ical outcomes.18 179 Over the same period as this review, 
nine Cochrane reviews have had direct relevance to the 
management of patients with burns.18 180–187 None could 
draw firm conclusions due to methodological issues 
including heterogeneity of outcome reporting. Hetero-
geneity is found in the reporting of outcomes relating 
to critical care, neurological illness, breast reconstruc-
tion surgery, prostate cancer, hip and knee replacement, 
oesophagectomy surgery, low back pain and in cardiac 
arrest trials among others.188–195 Variation in the defini-
tions of outcomes has also been found within published 
studies of other healthcare areas. A systematic review of 90 
papers reporting wound infection after general surgical 
procedures identified 41 definitions for wound infection 
itself, including three published by expert groups.196 
Similarly, a total of 56 definitions were identified from 97 
studies reporting anastomotic leak rates after gastrointes-
tinal surgery despite publication of a standard definition 
2 years before the beginning of the review.197
In this review, we identified and agreed the grouping of 
the 955 unique outcomes into 54 outcome domains. There 
is no agreement between COS reviewers about how best 
to classify outcomes into domains. Williamson published 
a taxonomy of categorising outcome domains.198 Other 
authors have suggested different ways of doing this, all 
addressing different needs32 33 199). In the Williamson 
taxonomy, the authors state that of 99 COS studies, 21 
applied their own approach to outcome classification 
and only six used an existing system. As we had identi-
fied a large number of different clinical burn outcomes 
and as the outcomes we extracted did not clearly fall 
within the Williamson taxonomy, we decided to use our 
own approach to domain classification. We used five 
multidisciplinary researchers and a patient working inde-
pendently, and subsequently together, to bring different 
views and as little bias as possible to the process.
A solution to the above described variation in outcome 
reporting across trials, is the development of a COS.21 200 201 
A COS is a minimum set of the most important outcomes, 
agreed and recommended for measurement in all trials for 
a particular condition.31 32 While not limiting choice, a COS 
will prespecify a set of outcomes to ensure consistency of 
reporting and the ability to collate evidence into systematic 
reviews by allowing researchers to compare ‘like with like’.33 
Trials can still select additional outcomes in addition to the 
minimum core set. This approach has been shown to improve 
the consistency of outcome reporting.202 203 Although there 
Figure 2 Reported timepoint at which outcome was assessed. mths, months; NS, not stated; yrs, years.
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Table 4 Outcome category, domains and examples of outcomes
Outcome category Outcome domain Outcome examples
No of unique 
outcomes per 
domain
Patient-reported Ability to carry out daily tasks Functional level of independence 1
Anxiety about medical procedures and 
appointments
Pain anxiety
Anxiety before dressing changes
4
Generalised anxiety General anxiety 1
Appearance Facial symmetry
Overall scar appearance
3
Blister fluid Amount of exudate 3
Burden of care Frequency of dressing changes
Time taken for daily wound cleaning
7
Comfort of dressings Dressing comfort 1
Psychological well-being Improvement in well-being 1
Mental ability 2
Quality and quantity of sleep Quantity of sleep
Incidence of sleep disturbance
17
Effect of scar on movement (contractures) Cognitive performance 3
Return to work/school or previous function Return to work or previous function 1
Burn wound pain Wound pain intensity at baseline
Pain tolerance
29
Donor site pain Donor site pain at rest
Donor site pain while walking
6
Pain during procedures Wound pain at dressing changes
Pain during hydrotherapy
14
Scar pain Functional scar pain
Incidence of neuropathic pain
13
Itch Baseline pruritus
Itch severity reduction
24
Pathophysiological Ability to fight infection Change in IgA
IL-1beta in blood
Serum interferon gamma levels
36
Body weight maintenance Incidence of weight loss
Body weight decrease from baseline
26
Bone strength Bone mineral density
Incidence of osteoporosis
30
Breathing and lungs Forced expiratory volume in 1 s
Functional residual capacity
27
Donor site problems after healing Donor site pigmentation
Sensation of donor site
24
Effect of burn on genes Gene expression patterns 1
Effect of burn on how the body uses energy Change in percentage of predicted resting energy 
expenditure
2
Effect on heart and blood circulation Incidence of cardiomegaly
Number of patients requiring norepinephrine
28
Fitness Maximum aerobic capacity
Exercise maximum minute ventilation
12
Growth in children Duration of growth arrest
Percentage change in height
10
How well muscles work Facial mimic function
Change in muscle function
9
Mobility Stride length
Knee range of motion
22
Kidney function Incidence of acute kidney injury
Requirement for renal replacement therapy
17
Liver function Hepatic function
Ammonia levels
11
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is no COS for burn care, work was undertaken in 2008 to 
agree a set of burn outcome domains.198 However, the work 
was undertaken by a small group of clinicians, lacked patient 
involvement and reported little methodological detail.204 
Considerable work to develop COS methodology has also 
been undertaken since this publication.205 206 The COMET 
Initiative disseminates resources for COS development and 
supports methodological developments in this area.207 208 
COMET recommends a four-step process to develop a COS: 
(a) agreement of the scope, (b) assessment of the need, (c) 
development of a protocol and finally (d) agreement of 
the COS.15 This systematic review has satisfied the first two 
phases for the development of a burn care COS. The final 
phase encompasses organising a comprehensive long-list of 
all potential outcomes into domains (of which the clinical 
domains for burn care are listed in table 4) and prioritising 
these domains using a consensus process.209–211
The strengths of this review are that the protocol and 
data extraction proforma were prespecified and the litera-
ture search was systematic and comprehensive, including 
Outcome category Outcome domain Outcome examples
No of unique 
outcomes per 
domain
Medical tests to indicate how unwell a patient is Albumin level
Change in pH
84
More than one organ failing (multiorgan failure) Incidence of multi organ failure
Percentage of patients with organ dysfunction
7
Muscle strength Knee extensor strength
Hamstring strength adjusted for body weight
30
Stomach and bowel function Days of diarrhoea
Incidence of abdominal distension
13
Burn wound healing Burn wound area at timepoints
Days until wound closure
166
Donor site healing Donor site healing to 90%
Time to donor site re-epithelialisation
9
Complications Complications of drug treatment Adverse drug reactions
Allergic dermatitis
52
Blood product transfusion Blood transfused per kg during hospitalisation
Total volume FFP transfused
11
Burn wound infection Wound bacterial colonisation
Wound contamination postoperatively
80
Death from burn injury Mortality related to burn size 1
Death from any cause Overall mortality
In-hospital mortality
14
Effects of fluid from a drip Incidence of fluid creep
Net fluid balance at specified times
17
Infections other than burn wound infection Incidence of central catheter related infections
Pulmonary infection
7
Sepsis Days of sepsis
Incidence of positive blood cultures
7
Scar-related Scar colour Erythema index
Scar melanin levels
25
Scar texture Scar height
Change in scar distensibility
47
Scar size Scar surface area 1
Treatment for scars Numbers of patients assessed for scar management
Numbers of patients needing scar management
2
Healthcare-related Costs of treatment for NHS/hospital Costs of analgesics for dressing changes
Pressure garment costs
14
Length of hospital stay Length of stay adjusted for burn size
Days in hospital
7
Length of stay in intensive care unit Length of ICU stay 3
Length of time on life support machine Duration of mechanical ventilation 1
Use of medicines to treat symptoms Pain relief required during dressing changes
Opioid consumption
12
FFP, fresh frozen plasma; ICU, intensive care unit; IL, interleukin; NHS, National Health Service.
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four major healthcare trial databases. To account for 
multidisciplinary perspectives, two researchers, two clini-
cians and a patient were involved in the domain process. 
It is also novel because it is the first to demonstrate, in 
detail and using systematic methodology, the scale of 
the heterogeneity of outcome reporting in burn care 
research. Limitations include the exclusion of publica-
tions in languages other than English. However, interna-
tional publications were included to reduce the risk of 
selection bias. The search was also time-limited which may 
have excluded outcomes from older studies. The reason 
for the time limitation was to identify research relevant to 
modern burn care. The search was also limited to trials 
reporting clinical outcomes. Other work is in progress to 
assess patient-reported outcomes in burn care research. 
This was a review undertaken systematically to a prespec-
ified protocol. However, a formal quality assessment of 
studies was not undertaken, as we were researching the 
reporting of outcomes and not attempting to analyse the 
effects of interventions. A COS for burn care research 
would address the issue of heterogeneity of outcome 
reporting between trials, lead to research that is more 
likely to measure relevant outcomes, enhance the value of 
burn care systematic reviews and reduce research waste.
COnClusIOn
We have shown that multiple different unique outcomes 
are reported in trials of burn care interventions. Different 
definitions are used to assess the same outcome issue and 
outcomes are measured at different time points after 
injury. This heterogeneity and inconsistency in outcome 
reporting prevent effective evidence synthesis and 
limits the quality of evidence available for clinical deci-
sion-making. Our review demonstrates that until greater 
consistency is achieved in outcome reporting in trials, it is 
unlikely that clinicians will be able to synthesise evidence 
across studies to understand the effects of surgical and 
non-surgical treatments following burn injury. It is recom-
mended that a burn care COS is developed to support the 
effective synthesis of trial data and allow more informed 
clinical decision-making for the benefit of patients.
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